Clinical manifestations are complex and often involve multi-systemic burdens. Early identification and standardized diagnosis are critical to improving prognosis. Diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory tests and pathological biopsies.
The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult-to-treat blood tumour diseases have been significantly improved. Treatment needs to closely monitor efficacy and adverse reactions, adapting timely to changes in the condition.
Multidisciplinary collaboration (MDT) is particularly important for the comprehensive management of family-specific spongiform vascular tumors (CCM1). 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.